Related Experiment Videos
[Phrenic nerve conduction in amyotrophic lateral sclerosis patients]
Li Zhuang1, Xiaofu Tang, Xianhao Xu
1Department of Neurology, Beijing Hospital, The fifth Hospital, Peking University, Beijing 100730, China.
Zhonghua Yi Xue Za Zhi
|April 16, 2002
Summary
Phrenic nerve conduction studies, measuring phrenic distal motor latency (PDML), are sensitive indicators of respiratory dysfunction in amyotrophic lateral sclerosis (ALS) patients, often detecting abnormalities before clinical symptoms appear.
Area of Science:
- Neurology
- Respiratory Medicine
- Electrophysiology
Context:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
- Respiratory muscle weakness is a primary cause of morbidity and mortality in ALS.
- Phrenic nerve conduction studies offer a potential method to assess diaphragmatic function.
Purpose:
- To evaluate the utility of phrenic nerve conduction parameters in patients with ALS.
- To correlate electrophysiological findings with respiratory function measures.
Summary:
- Diaphragmatic compound muscle action potential (DCMAP) latency and amplitude were measured in 44 ALS patients and 31 controls.
- Phrenic distal motor latencies (PDML) were significantly prolonged in ALS patients compared to controls.
- Abnormal PDML occurred more frequently than clinical dyspnea, suggesting early detection of respiratory involvement.
Impact:
- Phrenic nerve conduction, specifically PDML, serves as a sensitive electrophysiological marker for respiratory dysfunction in ALS.
- Combined assessment with central motor conduction time may provide a comprehensive understanding of respiratory control in ALS.